3D Bioprinting Market

3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021

Report Code: BT 4971 Jan, 2017, by marketsandmarkets.com

[143 Pages Report] Rising demand for organ transplantation to drive the market demand for 3D bioprinting market to reach USD 1.33 billion by 2021

The global 3D bioprinting market has been segmented on the basis of technology, applications, materials, and regions. By technology, the global market is segmented into four categories, namely, microextrusion, laser-assisted, inkjet, and magnetic 3D bioprinting. The microextrusion market is estimated to command the largest share of the global market in 2016, due to its high affordability and simple setup process.

The global market is projected to reach USD 1.33 billion by 2021 at a CAGR of 26.5% during forecast period. The key factor driving the growth of the market is the rising demand for organ transplantation across the globe. In addition, growing R&D in the field of 3D bioprinting, increasing public and private investments to support 3D bioprinting research, and rising use of 3D bioprinting in drug discovery are supporting the growth of this market. On the other hand, limitations of biomaterial-based products and socio-ethical concerns are the major challenges in this market.

As of 2015, Organovo Holdings Inc. (US) held the leadership position in the global market. Over the past three years, the company has adopted new product launches, product enhancements; strategic partnerships, collaborations, and agreements as its key business strategies to ensure its global dominance in this market.

The other key players in the market include EnvisionTEC GmbH (Germany), Nano3D Biosciences, Inc. (US), Cyfuse Biomedical K.K. (Japan), BioBots (US), Aspect Biosystems Ltd. (Canada), 3Dynamic Systems Ltd. (UK), regenHU Ltd (Switzerland), Cellink (Sweden), Regenovo Biotechnology Co., Ltd. (China), Poietis (France), and GeSiM (Germany), among others.

3D Bioprinting Market : Target Audience

  • 3D Bioprinter manufacturers, suppliers, and distributors
  • Pharmaceutical & biotechnology companies
  • Cosmetic product manufacturers, suppliers, and distributors
  • Healthcare institutions
  • Clinical diagnostic centers
  • Medical research laboratories
  • Academic medical centers and universities
  • Business research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report : 3D Bioprinting Market

This report categorizes the global market into the following segments and subsegments:

Global 3D Bioprinting Market, by Technology

  • Magnetic 3D Bioprinting
  • Laser-assisted Bioprinting
  • Inkjet 3D Bioprinting
  • Microextrusion 3D Bioprinting

Global 3D Bioprinting Market, by Material

  • Living Cells
  • Extracellular Matrices
  • Hydrogels
  • Other Biomaterials
  • *Other biomaterials include alginate, gelatin, and fibrinogen, among others

Global 3D Bioprinting Market, by Application

  • Clinical Applications
  • Skin
  • Bone
  • Blood Vessels
  • Research Applications
  • Drug and Medical Research
  • Regenerative Medicine
  • 3D Cell Culture

Global 3D Bioprinting Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World

3D Bioprinting Market : Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the market

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Increasing R&D initiatives for the use of living cells in the 3D bioprinting process to drive the global demand for Living Cells in the market

Living cells is most commonly used material in 3D bioprinting. They play a crucial role in the 3D bioprinting process as they have the ability to fabricate human scale tissues in a very defined and stable method.

In 2016, the living cells segment accounted for a share of 36.0% of the market. The growth in this segment is attributed to factors such as; increasing R&D initiatives for the use of living cells in 3D bioprinting; the expanding applications of this segment in 3D bioprinting; and growing research and awareness of stem cells among individuals across the globe.

3D Bioprinting Market Dynamics

3D Bioprinting Market

Increasing use of 3D bioprinting in drug discovery & screening to drive the market during the forecast period

Research Applications to register highest CAGR during forecast period

3D Bioprinting Market

Clinical Applications

Clinical applications of 3D bioprinting include the skin, bone & cartilage, and blood vessels. The increasing demand for organ transplantation and changing lifestyle of people across the globe will be the key growth drivers of the clinical applications segment of the market over the coming years. Among these sub-segments, skin printing is one of the major applications in the 3D bioprinting industry. Increasing cosmetic surgical procedures across the globe specifically in emerging countries is major factor contributing to the growth of this application segment.

Research Applications

Research applications of 3D bioprinting include drug and medical research, regenerative medicine, and 3D cell culture. Increasing initiatives taken by market players and university scientists in the 3D bioprinting field are the major contributors to the growth of the research applications market. Among these sub-segments, drug research is the major application for 3D bioprinting. Artificially bioprinted tissues enable researchers and pharmaceutical companies to study the effects of various drugs on different diseases, disease progression, and treatments within the required microenvironment, which is the major factor owing to the growth of this segment in the market.

Key Questions

  • What is the scope for emerging players to enter the market since industry giants are adopting strategic collaboration and acquisition to strengthen their distribution network?
  • What is current level of adoption of 3D bioprinting techniques in major countries? What changes in adoption pattern are expected for 3D bioprinted products moving forward?
  • What is the existing developmental pipeline for 3D bioprinted products/technologies of major market players?
  • How is the reimbursement structure for 3D bioprinting across various geographies; how will it impact the adoption of this technology moving forward?
  • What different materials for 3D bioprinting will be used for clinical applications worldwide in the coming years?

The global 3D bioprinting market is expected to reach USD 1,332.6 Million by 2021 from USD 411.4 Million in 2016, at a CAGR of 26.5% between 2016 and 2021.

On the basis of technology, the global market is segmented into four broad categories, namely, microextrusion, inkjet, laser-assisted, and magnetic 3D bioprinting. The microextrusion 3D bioprinting technology is estimated to command the largest share of the global market in 2016 due to its affordability, among other factors. The second-largest share is held by inkjet 3D bioprinting segment, due to its low cost and versatility as compared to other 3D bioprinting techniques.

By application, the market is segmented into clinical applications (including skin, bone, cartilage, and blood vessels) and research applications (including drug research, regenerative medicine, and 3D cell culture). The research applications segment holds the largest share in the market. Increasing initiatives by market players and university scientists in 3D bioprinting forms the major factor contributing to the growth of the research applications segment.

By material, the market is further segmented into extracellular matrices, hydrogels, living cells, and other biomaterials. The living cells segment is expected to account for the largest share of the market in 2016. Increasing R&D initiatives for the use of living cells in 3D bioprinting is one of the major factors driving the growth of the market. The hydrogels segment is expected to hold the second-largest share in the market, by material.

North America is expected to command the largest share of the 3D bioprinting market in 2016, owing to increasing government initiatives, rising demand for organ transplants, and rising awareness due to conferences and trade shows. Europe is estimated to account for the second-largest share of the market in 2016. The increasing number of 3D bioprinting-related conferences, large number of research activities, and increasing application of 3D bioprinting in the cosmetic industry are some key factors driving the growth of the European market.

The Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. The key factors influencing the growth of the Asia-Pacific market are the increase in overall and stem cell research activity, growing demand for organ transplantation, and rising initiatives by market players.

3D Bioprinting Market

Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), Nano3D Biosciences, Inc. (U.S.), Cyfuse Biomedical K.K. (Japan), BioBots (U.S.), Aspect Biosystems Ltd. (Canada), 3Dynamic Systems Ltd. (U.K.), regenHU Ltd (Switzerland), Cellink (Sweden), Regenovo Biotechnology Co., Ltd. (China), Poietis (France), and GeSiM (Germany) are some of the key players operating in the global market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
    1.5 Years Considered for the Study
    1.6 Currency
    1.7 Limitations
    1.8 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Methodology Steps
           2.1.1 Secondary and Primary Research Methodology
                    2.1.1.1 Secondary Research
                    2.1.1.2 Key Data From Secondary Sources
                    2.1.1.3 Primary Research
                    2.1.1.4 Key Data From Primary Sources
                    2.1.1.5 Key Industry Insights
    2.2 Market Size Estimation Methodology
    2.3 Research Design
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 27)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 32)
    4.1 3D Bioprinting: Market Overview
    4.2 Geographic Analysis: Market, By Technology (2016)
    4.3 Market Size, By Material, 2016 vs 2021 (USD Million)
    4.4 Market Size, By Application, 2016 vs 2021 (USD Million)
    4.5 Geographic Snapshot of the Market

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Demand for Organ Transplantation
                    5.2.1.2 Rise in Public and Private Funding to Support 3D Bioprinting Research Activities
                    5.2.1.3 Increasing Use of 3D Bioprinting in the Drug Discovery Process
                    5.2.1.4 Growing Focus of Market Players on 3D Bioprinting
           5.2.2 Restraints
                    5.2.2.1 Lack of Regulatory Guidelines Governing 3D Bioprinting
                    5.2.2.2 Dearth of Trained Professionals
           5.2.3 Opportunities
                    5.2.3.1 Increasing Stem Cell Research
                    5.2.3.2 Growing Awareness Related to 3D Bioprinting
                    5.2.3.3 Rising Adoption of 3D Bioprinting in the Cosmetic Industry
           5.2.4 Challenges
                    5.2.4.1 Socio-Ethical Concerns Related to the Use of 3D Bioprinted Products
                    5.2.4.2 Limitations of Biomaterial-Based Products
                    5.2.4.3 Lack of Complete Automation

6 Industry Insights (Page No. - 43)
    6.1 Introduction
    6.2 3D Bioprinting Approaches
           6.2.1 Biomimicry
           6.2.2 Autonomous Self-Assembly
           6.2.3 Mini-Tissue Building Blocks
    6.3 3D Bioprinting Patent Landscape
    6.4 Industry Trends
           6.4.1 Funding and Investments
           6.4.2 Partnerships, Agreements, and Collaborations
           6.4.3 Conferences and Symposiums

7 3D Bioprinting Market, By Technology (Page No. - 47)
    7.1 Introduction
    7.2 Magnetic 3D Bioprinting
    7.3 Laser-Assisted Bioprinting
    7.4 Inkjet 3D Bioprinting
    7.5 Microextrusion Bioprinting

8 3D Bioprinting Market, By Material (Page No. - 56)
    8.1 Introduction
    8.2 Hydrogels
    8.3 Extracellular Matrices
    8.4 Living Cells
    8.5 Other Biomaterials

9 3D Bioprinting Market, By Application (Page No. - 64)
    9.1 Introduction
    9.2 Clinical Applications
           9.2.1 Skin
           9.2.2 Bone & Cartilage
           9.2.3 Blood Vessels
    9.3 Research Applications
           9.3.1 Drug Research
           9.3.2 Regenerative Medicine
           9.3.3 3D Cell Culture

10 Market By Region (Page No. - 75)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Rest of Europe (RoE)
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 107)
     11.1 Overview
     11.2 Market Ranking Analysis
     11.3 Competitive Situation and Trends
             11.3.1 Agreements, Partnerships, & Collaborations
             11.3.2 Product Launches, Developments, and Commercialization
             11.3.3 Product Showcases, Exhibitions, and Presentations
             11.3.4 Funding
             11.3.5 Other Strategies

12 Company Profiles (Page No. - 114)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
     12.2 Organovo Holdings, Inc.
     12.3 Envisiontec GmbH
     12.4 Nano 3D Biosciences, Inc.
     12.5 Cyfuse Biomedical K.K.
     12.6 Regenhu Ltd.
     12.7 Aspect Biosystems Ltd.
     12.8 Biobots
     12.9 Cellink
     12.10 Gesim
     12.11 Poietis
     12.12 Regenovo Biotechnology Co., Ltd.
     12.13 3Dynamic Systems Ltd.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 135)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (74 Tables)

Table 1 Patents, 2015–2016
Table 2 Market Size, By Technology, 2014-2021 (USD Million)
Table 3 Magnetic Market Size, By Region, 2014–2021 (USD Million)
Table 4 Laser-Assisted Market Size, By Region, 2014–2021 (USD Million)
Table 5 Inkjet Market Size, By Region, 2014–2021 (USD Million)
Table 6 Microextrusion Market Size, By Region, 2014–2021 (USD Million)
Table 7 Market Size, By Material, 2014-2021 (USD Million)
Table 8 Hydrogels Market Size, By Region, 2014–2021 (USD Million)
Table 9 Extracellular Matrices Market Size, By Region, 2014–2021 (USD Million)
Table 10 Living Cells Market Size, By Region, 2014–2021 (USD Million)
Table 11 Other Biomaterials Market Size, By Region, 2014–2021 (USD Million)
Table 12 Market Size, By Application, 2014-2021 (USD Million)
Table 13 Clinical Applications Market Size, By Type, 2014-2021 (USD Million)
Table 14 Clinical Applications Market Size, By Region, 2014–2021 (USD Million)
Table 15 Skin Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 16 Bone & Cartilage Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 17 Blood Vessel Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 18 Research Applications Market Size, By Type, 2014-2021 (USD Million)
Table 19 Research Applications Market Size, By Region, 2014–2021 (USD Million)
Table 20 Drug Research Market Size, By Region, 2014–2021 (USD Million)
Table 21 Regenerative Medicine Market Size, By Region, 2014–2021 (USD Million)
Table 22 3D Cell Culture Market Size, By Region, 2014–2021 (USD Million)
Table 23 Market Size, By Region, 2014–2021 (USD Million)
Table 24 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 25 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 26 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 27 North America: Market Size, By Material, 2014–2021 (USD Million)
Table 28 U.S.: Market Size, By Technology, 2014–2021 (USD Million)
Table 29 U.S.: 3D Bioprinting Market Size, By Application, 2014–2021 (USD Million)
Table 30 U.S.: Market Size, By Material, 2014–2021 (USD Million)
Table 31 Canada: Market Size, By Technology, 2014–2021 (USD Million)
Table 32 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 33 Canada: Market Size, By Material, 2014–2021 (USD Million)
Table 34 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 35 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 36 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 37 Europe: Market Size, By Material, 2014–2021 (USD Million)
Table 38 Germany: Market Size, By Technology, 2014–2021 (USD Million)
Table 39 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 40 Germany: Market Size, By Material, 2014–2021 (USD Million)
Table 41 France: Market Size, By Technology, 2014–2021 (USD Million)
Table 42 France: Market Size, By Application, 2014–2021 (USD Million)
Table 43 France: Market Size, By Material, 2014–2021 (USD Million)
Table 44 U.K.: Market Size, By Technology, 2014–2021 (USD Million)
Table 45 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 46 U.K.: Market Size, By Material, 2014–2021 (USD Million)
Table 47 RoE: Market Size, By Technology, 2014–2021 (USD Million)
Table 48 RoE: Market Size, By Application, 2014–2021 (USD Million)
Table 49 RoE: Market Size, By Material, 2014–2021 (USD Million)
Table 50 Asia-Pacific: Market Size, By Country, 2014–2021 (USD Million)
Table 51 Asia-Pacific: Market Size, By Technology, 2014–2021 (USD Million)
Table 52 Asia-Pacific: Market Size, By Application, 2014–2021 (USD Million)
Table 53 Asia-Pacific: Market Size, By Material, 2014–2021 (USD Million)
Table 54 Japan: Market Size, By Technology, 2014–2021 (USD Million)
Table 55 Japan: Market Size, By Application, 2014–2021 (USD Million)
Table 56 Japan: Market Size, By Material, 2014–2021 (USD Million)
Table 57 China: Market Size, By Technology, 2014–2021 (USD Million)
Table 58 China: Market Size, By Application, 2014–2021 (USD Million)
Table 59 China: Market Size, By Material, 2014–2021 (USD Million)
Table 60 India: Market Size, By Technology, 2014–2021 (USD Million)
Table 61 India:  Market Size, By Application, 2014–2021 (USD Million)
Table 62 India: Market Size, By Material, 2014–2021 (USD Million)
Table 63 RoAPAC: Market Size, By Technology, 2014–2021 (USD Million)
Table 64 RoAPAC: Market Size, By Application, 2014–2021 (USD Million)
Table 65 RoAPAC: Market Size, By Material, 2014–2021 (USD Million)
Table 66 RoW: Market Size, By Technology, 2014–2021 (USD Million)
Table 67 RoW: Market Size, By Application, 2014–2021 (USD Million)
Table 68 RoW: Market Size, By Material, 2014–2021 (USD Million)
Table 69 Agreements, Partnerships, and Collaborations, 2013–2016
Table 70 Top 5 Product Launches, Developments, and Commercialization, 2013–2016
Table 71 Product Showcases, Exhibitions, and Presentations, 2013–2016
Table 72 Top 5 Funding, 2013–2016
Table 73 Other Strategies, 2013–2016
Table 74 Product Mix of the 3D Bioprinter Market Players


List of Figures (39 Figures)

Figure 1 Global 3D Bioprinting Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Bottom-Up Approach
Figure 4 Research Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Data Triangulation Methodology
Figure 7 Global Market, By Technology
Figure 8 Global Market, By Application
Figure 9 Global Market, By Material
Figure 10 Geographic Snapshot of the Global Market
Figure 11 Rising Demand for Organ Transplantation is Driving Growth in the Market
Figure 12 Microextrusion 3D Bioprinting to Dominate the Global Market in 2016
Figure 13 Living Cells to Command the Largest Share in the Market in 2016
Figure 14 Research Applications Will Continue to Dominate the Global Market in 2021
Figure 15 North America to Command the Largest Share in the Global Market in 2016
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Microextrusion 3D Bioprinting Segment to Witness High Growth During the Forecast Period
Figure 18 Asia-Pacific to Witness High Growth During the Forecast Period
Figure 19 North America to Hold A Major Share in the Laser-Assisted Market
Figure 20 Asia-Pacific to Witness High Growth During the Forecast Period
Figure 21 North America to Hold A Major Share in the Microextrusion Market
Figure 22 Living Cells Segment to Register Highest Growth During the Forecast Period
Figure 23 North America to Hold the Largest Share in the Hydrogels Market, in 2016 and 2021
Figure 24 Asia-Pacific Segment to Register Highest Growth During the Forecast Period
Figure 25 North America to Hold the Largest Share in the Living Cells Market During the Forecast Period
Figure 26 North America to Hold Largest Share of the Other Biomaterials Market in 2016
Figure 27 Research Applications Segment to Witness Highest Growth During the Forecast Period
Figure 28 Skin Segment to Register Highest Growth During the Forecast Period
Figure 29 North America to Command Largest Share During the Forecast Period
Figure 30 Drug Research Segment to Register Highest Growth During the Forecast Period
Figure 31 Asia-Pacific to Witness Highest Growth During the Forecast Period
Figure 32 Market Growth Forecast, By Region (2016–2021)
Figure 33 North America: Market Snapshot
Figure 34 Europe: Market Snapshot
Figure 35 APAC: Market Snapshot
Figure 36 Leading Market Players Adopted Agreement, Collaboration, and Partnership as Their Key Growth Strategy Over the Last Three Years (2013–2016)
Figure 37 Market Ranking By Key Player, 2015
Figure 38 Battle for Market Share: Agreement, Collaboration, and Partnership Was the Key Strategy Adopted By Market Players
Figure 39 Company Snapshot: Organovo Holdings, Inc.


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 4971
Published ON
Jan, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the 3D Bioprinting Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved